India In Vitro Fertilization Market (By Instrument: Equipment, Culture Media; By Procedure Type: Fresh Nondonor; By Providers) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

India In Vitro Fertilization Market Size and Trends

The India In vitro fertilization market size was estimated at around USD 1.08 billion in 2023 and it is projected to hit around USD 2.3 billion by 2033, growing at a CAGR of 7.83% from 2024 to 2033.

India In Vitro Fertilization Market Size 2024 to 2033

Key Pointers

  • By Instrument, the culture media held the largest revenue share of 41% in 2023.
  • By Instrument, the disposable devices segment is estimated to expand the fastest CAGR during the forecast period.
  • By Procedure Type, the frozen nondonor procedures segment registered the maximum market share in 2023.
  • By Procedure Type, the fresh donor segment is anticipated to grow at the noteworthy CAGR from 2024 to 2033.
  • By Provider, the fertility clinics dominated the market and are expected to grow at the fastest CAGR from 2024 to 2033.

India In Vitro Fertilization Market Overview

The In vitro fertilization (IVF) market in India has witnessed significant growth driven by increasing infertility rates, changing lifestyles, and advancements in medical technology. IVF procedures involve fertilizing an egg with sperm outside the body, often used when natural conception is difficult or unsuccessful.

India In Vitro Fertilization Market Growth Factors

The India In vitro fertilization (IVF) market is experiencing robust growth driven by an increasing infertility rates, fueled by factors such as changing lifestyles and delayed pregnancies, have significantly expanded the market's potential. Technological advancements in IVF procedures, including innovations in embryo transfer techniques and genetic testing, have enhanced success rates and broadened the appeal of IVF as a viable fertility treatment option. Moreover, rising awareness and acceptance of infertility treatments, coupled with supportive government initiatives aimed at improving accessibility and affordability of IVF services, have further propelled market growth. Additionally, India's emergence as a medical tourism hub for cost-effective, high-quality IVF treatments has attracted a growing number of international patients, contributing to the market's expansion.

India In Vitro Fertilization Market Trends:

  • Rising Demand for Donor Eggs and Sperm: Increasing acceptance and accessibility of donor gametes are addressing fertility challenges, particularly among older couples or those with specific genetic conditions.
  • Shift towards Single Embryo Transfers (SET): Growing emphasis on reducing multiple pregnancies and associated health risks is driving the adoption of SET procedures, supported by advancements in embryo selection technology.
  • Increasing Adoption of Natural Cycle and Minimal Stimulation IVF: Rising preference for less invasive and cost-effective IVF approaches is fueling the adoption of natural cycle and minimal stimulation protocols, aimed at reducing patient discomfort and treatment costs.
  • Expanding Role of Genetic Testing: Growing utilization of preimplantation genetic testing (PGT) to screen embryos for genetic disorders and chromosomal abnormalities is improving embryo selection precision and enhancing treatment outcomes.
  • Telemedicine and Virtual Consultations: Accelerated adoption of telemedicine platforms for initial consultations, follow-ups, and treatment monitoring is enhancing patient convenience and expanding access to specialized fertility care, particularly in remote areas.

India In Vitro Fertilization Market Restraints:

  • Limited Insurance Coverage: Insufficient insurance coverage for fertility treatments in India means that a substantial portion of treatment costs must be borne out-of-pocket by patients, restricting affordability and accessibility.
  • Variable Success Rates: Despite technological advancements, IVF success rates can vary significantly depending on factors such as patient age, reproductive health, and treatment protocols, leading to uncertainty and disappointment for some patients.
  • Psychological and Emotional Impact: The emotional toll of fertility treatments, including stress, anxiety, and depression, can be substantial for individuals and couples undergoing IVF, impacting overall well-being and treatment adherence.
  • Shortage of Skilled Specialists: A shortage of trained fertility specialists and embryologists in some regions of India limits the capacity of clinics to meet growing demand for IVF services, leading to longer wait times and potential quality issues.

Instrument Insights

In 2023, culture media dominated the market with a share of approximately 41%. This was driven by increased research and development efforts aimed at enhancing culture media, alongside improved funding availability. For example, in June 2023, Gold Standard Diagnostics launched BACGro Culture Media, designed to detect pathogenic microorganisms in the food, environmental, and pharmaceutical sectors. The BACGro product line includes dehydrated and liquid media that meet global standards and reference methods.

The disposable devices segment is expected to exhibit the highest compound annual growth rate (CAGR) during the forecast period. Growth in this segment is attributed to the introduction of disposable devices like slides, needles, and chambers, which comply with sterility and regulatory requirements. These advancements are projected to increase the adoption of disposable IVF devices. Recent innovations include disposable slides for sperm counting, imaging-based systems to isolate motile sperm, and disposable microchips. For instance, in May 2022, DPU IVF and Endoscopy Center introduced the Time-Lapse Imaging Embryoscope in Pune, enhancing IVF treatment outcomes by significantly improving live birth rates and reducing early pregnancy loss rates.

Procedure Type Insights

In 2023, frozen nondonor procedures accounted for the largest share of market revenue. This is attributed to their cost-effectiveness compared to fresh embryo transfers or donor eggs, the increasing success of IVF procedures, and advancements in genetic testing. Genetic testing advancements enable embryo screening for genetic disorders prior to implantation, encouraging the use of frozen embryos for selecting healthier options. In December 2023, Progenesis expanded its operations into India with the launch of its first genetic laboratory in New Delhi.

The fresh donor segment is projected to grow at the fastest CAGR during the forecast period, driven by rising demand for donor eggs and sperm due to increasing infertility rates. India's large population pool and socio-cultural factors contribute to a significant supply of potential egg donors, supporting clinics in offering diverse donor options, including fresh donations. Additionally, anonymous donation options further expand the donor pool. For example, in June 2023, LifeCell International Pvt. Ltd. introduced OvaScore, SpermScore, and InferGenes kits, enabling private and convenient sample collection for sexual, reproductive, women's, and baby health services.

Provider Insights

In 2023, fertility clinics dominated the market and are expected to grow at the fastest CAGR during the forecast period. This growth is driven by increased demand for assisted reproductive technology (ART) treatments and the expansion of ART centers and fertility clinics. Factors such as specialist availability, cost-effectiveness, and reduced risks of Hospital-Acquired Infections (HAIs) further support this trend. For instance, in January 2024, CK Birla Healthcare Pvt. Ltd. launched a new fertility clinic in Meerut, Uttar Pradesh.

India In Vitro Fertilization Market Key Companies

  • CK Birla Healthcare Pvt. Ltd.
  • Nova IVF
  • Indira IVF Hospital Private Limited.
  • Apollo Fertility (Apollo Specialty Hospitals Pvt. Ltd.)
  • Max Healthcare
  • MANIPAL HEALTH ENTERPRISES PVT LTD
  • Bloom Fertility Centre
  • BACC Healthcare Private Limited
  • Cloudnine Hospitals
  • Morpheus IVF
  • Babies and Us Fertility and IVF Centre (Ind) Pvt Ltd

Recent Developments

  • December 2023: Little Angel IVF introduced personalized fertility consultations, comprehensive diagnostic services, advanced IVF treatments, and intracytoplasmic sperm injection (ICSI) specifically tailored for Non-Resident Indian patients.
  • June 2023: Nova IVF acquired WINGS IVF, a regional IVF chain based in Ahmedabad, thereby expanding its network to 68 centers across 44 cities.
  • March 2023: Santaan inaugurated a new fertility clinic and research institute in Odisha, India, aimed at enhancing fertility care and research in the region.
  • March 2023: Indira IVF opened its 116th IVF center in Pune, Maharashtra, as an expansion of its existing presence in the city.

India In Vitro Fertilization Market Segmentation:

By Instrument

  • Disposable Devices
  • Culture Media
    • Cryopreservation Media
    • Embryo Culture Media
    • Ovum Processing Media
    • Sperm Processing Media
  • Equipment
    • Sperm Analyzer Systems
    • Imaging Systems
    • Ovum Aspiration Pumps
    • Micromanipulator Systems
    • Incubators
    • Gas Analyzers
    • Laser Systems
    • Cryosystems
    • Sperm Separation Devices
    • IVF Cabinets
    • Anti-vibration Tables
    • Witness Systems
    • Other

By Procedure Type

  • Fresh Donor
  • Frozen Donor
  • Fresh Non-donor
  • Frozen Non-donor

By Providers

  • Fertility Clinics
  • Hospitals & Others Setting

Frequently Asked Questions

The India In vitro fertilization market size was reached at USD 1.08 billion in 2023 and it is projected to hit around USD 2.3 billion by 2033.

The India In vitro fertilization market is growing at a compound annual growth rate (CAGR) of 7.83% from 2024 to 2033.

The driving factors of the India In Vitro Fertilization (IVF) market include increasing infertility rates, advancements in medical technology, and growing acceptance of assisted reproductive techniques.

The leading companies operating in the India In vitro fertilization market are Nova IVF, Indira IVF Hospital Private Limited, and CK Birla Healthcare Pvt. Ltd., Max Healthcare, Bloom Fertility Centre, and MANIPAL HEALTH ENTERPRISES PVT LTD.

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers